Cardiff Oncology (CRDF) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Cardiff Oncology (CRDF) over the last 15 years, with Q2 2025 value amounting to $4.3 million.
- Cardiff Oncology's Accumulated Depreciation & Amortization rose 198937.2% to $4.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.3 million, marking a year-over-year increase of 198937.2%. This contributed to the annual value of $4.1 million for FY2024, which is 93944.72% up from last year.
- According to the latest figures from Q2 2025, Cardiff Oncology's Accumulated Depreciation & Amortization is $4.3 million, which was up 198937.2% from $4.2 million recorded in Q1 2025.
- In the past 5 years, Cardiff Oncology's Accumulated Depreciation & Amortization ranged from a high of $4.3 million in Q2 2025 and a low of $31000.0 during Q1 2022
- Its 5-year average for Accumulated Depreciation & Amortization is $1.1 million, with a median of $232000.0 in 2021.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 7394.96% in 2022, then skyrocketed by 404705.88% in 2025.
- Cardiff Oncology's Accumulated Depreciation & Amortization (Quarter) stood at $451000.0 in 2021, then plummeted by 47.67% to $236000.0 in 2022, then surged by 68.64% to $398000.0 in 2023, then soared by 939.45% to $4.1 million in 2024, then increased by 4.54% to $4.3 million in 2025.
- Its Accumulated Depreciation & Amortization was $4.3 million in Q2 2025, compared to $4.2 million in Q1 2025 and $4.1 million in Q4 2024.